WHY EXPERIEN GROUP

Veranex is committed to helping its clients achieve their innovation objectives and accelerating time to market, and this acquisition is a huge step in that direction. With Experien Group’s long-standing FDA engagement, global regulatory guidance experience, and successful track record of approvals, Veranex’s clients will benefit greatly from this new addition.

OUR STRATEGY

Veranex’s strategy is to provide integrated product development strategies and services across the MedTech product life cycle. By combining product development, regulatory, and market access expertise, Veranex offers a unique, end-to-end solution to its clients. With the acquisition of Experien Group, Veranex’s West Coast operations now offer a client-responsive consulting model that can adjust to meet client program requirements.